{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:48:09Z","timestamp":1793119689799,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejim.2025.106536","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:09:44Z","timestamp":1759860584000},"page":"106536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6521-9592","authenticated-orcid":false,"given":"Gabri\u00eblla","family":"von Kreijfelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Joanne","family":"Holtrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-6183","authenticated-orcid":false,"given":"Juli\u00ebtte","family":"Zwaveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2025.106536_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10916-024-02070-2","article-title":"An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records","volume":"48","author":"Abedian Kalkhoran","year":"2024","journal-title":"J Med Syst"},{"key":"10.1016\/j.ejim.2025.106536_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127549","article-title":"Strengthening spontaneous reporting-based signal detection during a pandemic with cases from electronic health records using a natural language processing tool","volume":"62","author":"van der Weg","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejim.2025.106536_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"Suppl_2","key":"10.1016\/j.ejim.2025.106536_bib0004","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/jac\/dkac351","article-title":"Lass-fl\u00f6rl C. Liposomal amphotericin B-the past","volume":"77","author":"Br\u00fcggemann","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ejim.2025.106536_bib0005","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1875-9114.1998.tb03915.x","article-title":"Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B","volume":"18","author":"Barcia","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.ejim.2025.106536_bib0006","article-title":"Amphotericin B in the era of new antifungals: where will it stand?","volume":"10","author":"Akinosoglou","year":"2024","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.ejim.2025.106536_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal Amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejim.2025.106536_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1432-1033.1991.tb15908.x","article-title":"Effects of amphotericin B on the glucose metabolism in Saccharomyces cerevisiae cells. Studies by 13C-, 1H-NMR and biochemical methods","volume":"197","author":"Tran-Dinh","year":"1991","journal-title":"Eur J Biochem"},{"issue":"10","key":"10.1016\/j.ejim.2025.106536_bib0009","first-page":"433","article-title":"Acute refractory hyperkalaemia and fatal cardiac arrest related to administration of liposomal amphotericin B","volume":"66","author":"Groot","year":"2008","journal-title":"Neth J Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106536_bib0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0005-2736(82)90360-1","article-title":"Changes in erythrocyte permeability due to palytoxin as compared to amphotericin B","volume":"688","author":"Ahnert-Hilger","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2025.106536_bib0011","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3181\/00379727-118-29825","article-title":"Potassium loss from HUMAN erythrocytes exposed to amphotericin B","volume":"118","author":"Butler","year":"1965","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106536_bib0012","first-page":"244","article-title":"Characteristics of amphotericin B-induced endothelial cell injury","volume":"121","author":"Cutaia","year":"1993","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.106536_bib0013","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diagmicrobio.2017.10.018","article-title":"Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: a retrospective analysis","volume":"90","author":"Yamazaki","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ejim.2025.106536_bib0014","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/AAC.41.4.728","article-title":"Serum pharmacology of amphotericin B applied in lipid emulsions","volume":"41","author":"Heinemann","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ejim.2025.106536_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myac074","article-title":"Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study","volume":"60","author":"Van Daele","year":"2022","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106536_bib0016","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.dmpk.2015.08.003","article-title":"Pharmacokinetic evaluation of liposomal amphotericin B (L-AMB) in patients with invasive fungal infection: population approach in Japanese pediatrics","volume":"30","author":"Ohata","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.ejim.2025.106536_bib0017","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/dkae003","article-title":"Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review","volume":"79","author":"Lai","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 4","key":"10.1016\/j.ejim.2025.106536_bib0018","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1093\/cid\/ciz076","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B","volume":"68","author":"Groll","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"11","key":"10.1016\/j.ejim.2025.106536_bib0019","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation","volume":"26","author":"Gomez-Lopez","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ejim.2025.106536_bib0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/08982104.2016.1205087","article-title":"AmBisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety\/efficacy","volume":"27","author":"Takemoto","year":"2017","journal-title":"J Liposome Res"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:15:56Z","timestamp":1764659756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525004133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"alternative-id":["S0953620525004133"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106536","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106536"}}